GLP-1

AI-Powered Obesity Care: FlyteHealth Delivers Big Wins for Connecticut’s Public Employees

In an era where access to effective obesity care remains mired in controversy over medication costs and payer reluctance, a…

5 months ago

The Evolving Landscape of Anti-Obesity Drugs

Obesity has become a global health crisis, with an estimated 16% of the world’s adult population classified as obese. The…

8 months ago

The Weight Loss Drugs That Refuse to Recognize Boundaries

Drugs in the GLP-1 category are now being seen in a different light beyond that of weight control, and their…

12 months ago

Obesity Treatment Is Not Just About Weight Loss

Obesity care goes beyond mere body weight reduction in a number of ways, all of which tie back to an…

2 years ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More